Developments in radiotherapy and adjuvant chemotherapy for head and neck cancer.
Glaholm
John
J
Watkinson
John C
JC
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015687:Cell Hypoxia / Q000187:drug effects / Q000528:radiation effects; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D019583:Dose Fractionation, Radiation; D017341:Etanidazole / Q000494:pharmacology* / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D008920:Misonidazole / Q000494:pharmacology* / Q000627:therapeutic use*; D009536:Niacinamide / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000970:Antineoplastic Agents; D014665:Vasodilator Agents; D009536:Niacinamide; D017341:Etanidazole; D008920:Misonidazole